The Indian Drug Manufacturers' Association (IDMA) has encouraged the National Pharmaceutical Pricing Authority (NPPA) to apply prospective batch pricing to eliminate overcharging and ensure business comfort...
In businesses like the pharmaceutical industry, where producers make vast numbers of small items, economies of scale are crucial.
The US Food and Drug Administration on Friday approved Krystal Biotech Inc's topical gene therapy for patients with a genetic skin disorder, making it the first-of-its kind treatment for epidermolysis bullosa. The therapy, Vyjuvek, has been...
Strides Pharma Science Ltd announced this week that the US Food and Drug Administration (FDA) has issued an establishment inspection report (EIR) for its Puducherry manufacturing facility. The US Food and Drug Administration issues an EIR upon...
Enveric Biosciences, Inc., a biotechnology company, announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a patent application involving EB-373, the company's new chemical entity (NCE) psilocin...
Debiopharm, a privately held Swiss biopharmaceutical company aiming to establish tomorrow's standards of care to cure cancer and infectious diseases, has announced the start of an open-label phase 1/2 study evaluating Debio 0123, a brain-penetrant...
edtronic plc, the global leader in healthcare technology, has announced an investment of approximately Rs. 3,000 crore (more than US$ 350 million) to expand the Medtronic Engineering & Innovation Centre (MEIC) in Hyderabad, in a significant step...
Modality Solutions, a trusted cold chain engineering partner for leading biopharmaceutical companies, and CSafe, the market leader in providing a comprehensive suite of thermal shipping solutions for the biopharmaceutical cold chain, have announced..
Tagrisso, a cancer medicine developed by AstraZeneca, was used with chemotherapy to treat patients with a kind of lung cancer in a late-stage experiment, the firm announced later this week.
Emcure Pharmaceuticals Limited (EPL) announced the launch of Orofer FCM 750, a new parenteral iron brand containing Ferric carboxymaltose (FCM). The new dosage variant is intended to provide a more effective and convenient option for patients with...